Medical Letter on the CDC & FDA
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC & FDA
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Business Update
Molecular diagnostics company announces expansion of diagnostic pipeline
December 12th, 2004
Third Wave Technologies Inc. (TWTI) provided new details about the expansion of the company's molecular diagnostic pipeline and issued preliminary guidance for 2005 clinical molecular diagnostic revenue. Products to be released during 2005 and multiple products in development include those that extend the company's infectious disease offerings and new oncology products. In addition to its near-term pipeline of genetics products, the company also has multiple products in feasibility and is evaluating the development of a product for the detection of Ashkenazi Jewish mutations. Third Wave entered the infectious disease market during...
Source: Medical Letter on the CDC & FDA (2004-12-12)
|
